{"id":201798,"name":"ELI LILLY & CO.","slug":"eli-lilly-co","state":"DC","country":"United States of America","description":"pharmaceutical corporation","totalSpending":532000,"filings":8,"yearlySpending":[{"year":2018,"income":264000},{"year":2019,"income":268000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"TRD","display":"Trade (domestic/foreign)"}],"firms":["GUIDEPOSTSTRATEGIES, LLC"],"lobbyists":["PHIL COX","LARISSA MARTIN"],"govEntities":["Commerce, Dept of (DOC)","Executive Office of the President (EOP)","Office of the Vice President of the United States","U.S. Trade Representative (USTR)","Health & Human Services, Dept of (HHS)","Office of Management & Budget (OMB)","SENATE"],"sampleDescriptions":["drug pricing, Japan - pricing reform internationally","drug pricing, Japan - pricing reform internationally NAFTA OECD Trade Committee","drug pricing","drug pricing NAFTA OECD Trade Committee","drug pricing"]}